Navigation Links
WavePharma Unveils Proprietary Chitosan-Based Delivery System for Controlled Release of Key Ingredients in Personal Care Products

New Orleans, LA (PRWEB) December 11, 2013

WavePharma, LLC, developer of an innovative, extended release and transdermal delivery technology, WP-ChitosanTM, announced today the launch of its modified chitosan for use in the multi-billion dollar cosmetics and pharmaceutical industries. WavePharma is actively seeking development partners to integrate these materials into their personal and skin care formulations.

Native, unmodified chitosan comes from chitin, a natural substance that has been a mainstay in many skin and hair care products for years because of its moisturizing, protective, elastic, antibacterial/antifungal, and biodegradable properties. WavePharma’s modified chitosan retains these properties, plus unlocks premium benefits such as adjustable water retention (hydration), custom bonding of molecules or active ingredients, superior adhesion compared with market leading products, the ability to control the thickness of gels and creams, as well as the ability to control the release of active ingredients and therapeutic agents.

“Our WP-chitosan is more than just a technical advancement, a new feature, or even a new product; it’s a new material. It is chitosan-based, but it’s chemically and physically different than non-modified chitosan and has a number of novel, useful properties to advance skin care, transdermal delivery of active agents, and hair care,” said Jack Foster, CEO of WavePharma.

Much of the WP-chitosan proof-of-concept work to date was sponsored by a market leader in eye medications and focused on controlled release of drugs in the eye. WP-chitosan modified pharmaceutical agents demonstrated long-term retention on the cornea and extended agent delivery profiles and bioavailability. WavePharma is evaluating chitosan-enhanced products for improved retention of actives for the skin and hair. The company has engaged innovation solutions leader Emergent Technologies, Inc. to identify new applications and secure ‘cosmeceutical’ partners looking for science-based solutions for differentiated products using this novel and proprietary delivery system.

“The potential applications of WP-chitosan technology range from extending the efficacy of sunscreen on the skin to creating the ultimate moisturizer that attracts and retains water,” said Kris Looney, Emergent Technologies President. “We anticipate the benefits of this technology will enhance products by improving their performance, satisfying consumer desires for greener products while producing differentiation for our select industry partners increasing their profit margins.”

For additional information about the technology and partnership opportunities, interested parties should visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference
2. Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salems Growing Piedmont Triad Research Park
3. SPYru™ unveils "The Uberwater"
4. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
5. UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
6. Opedix® Kinetic Health Gear Unveils New KNEE-Tec™ Knee Support Tights Shown to Reduce Quadriceps Muscle Fatigue and Knee Pain
7. Opedix® Joint Support Compression Apparel Unveils New CORE-Tec™ Shorts, Tested to Improve Core Stability, and Offer Support for Low Back Pain during Athletic Activities
8. Microsoft Unveils Dynamics GP 2013 – A Landmark Release to the ERP Solution
9. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
10. Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
11. Family Tree DNA Unveils $39 DNA Test in Major Step Toward Universal Access by Individuals to their Own Genetic Data
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
Breaking Biology News(10 mins):